NCT06452069 - Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients | Biotech Hunter

Enrollment

280

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

May 15, 2025

Study Completion Date

September 15, 2025

Conditions

COVID-19 Respiratory InfectionCOVID-19

Interventions

OTHER

IMMUNO19

"280 participants will be divided into 2 groups. There will be 140 participants in the groups.~The 1st group will receive IMMUNO19 10 mL one time, The 2nd group will receive Placebo 10 mL for one time."

Trial Locations (10)

34212

Bağcılar Training and Research Hospital, Istanbul

34255

Gaziosmanpaşa Training and Research Hospital, Istanbul

34384

Cemil Taşcıoğlu City Hospital, Istanbul

34722

Göztepe Süleyman Yalçın City Hospital, Istanbul

34764

Umraniye Training and Research Hospital, Istanbul

34844

Süreyyapaşa Chest Disease and Thoracic Surgery Training and Research Hospital, Istanbul

34865

Kartal Dr. Lütfi Kırdar City Hospital, Istanbul

41060

Kocaeli City Hospital, Kocaeli

07070

Akdeniz University, Antalya

07040

Antalya Atatürk Public Hospital, Antalya

All Listed Sponsors

collaborator

Gama CRO Tıbbi IIac Arastirma Org.Tic.Ltd.Sti

UNKNOWN

lead

Biodex S.A

INDUSTRY